Company: GEHC
Filing Date: 2025-06-05
Form Type: 424B2
Source: 0001193125-25-135863
Chunk: 0

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-06-05
Form: 424B2
Chunk 0
---
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-280584 Prospectus Supplement to Prospectus dated June 28, 2024 $1,500,000,000 GE HealthCare Technologies Inc. $650,000,000 4.800% Senior Notes due 2031 $850,000,000 5.500% Senior Notes due 2035 We are offering $650,000,000 aggregate principal amount of 4.800% senior notes due 2031 (the “2031 notes”), and $850,000,000 aggregate principal amount of 5.500% senior notes due 2035 (the “2035 notes”). The 2031 notes will bear interest at a rate of 4.800% per annum. The 2035 notes will bear interest at a rate of 5.500% per annum. Interest on the 2031 notes will be payable in cash semi-annually in arrears on January 15 and July 15 of each year, beginning on January 15, 2026. Interest on the 2035 notes will be payable in cash semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2025. The 2031 notes will mature on January 15, 2031 and the 2035 notes will mature on June 15, 2035. We refer to the 2031 notes and the 2035 notes collectively as the “notes.” We may redeem notes of either series at any time and from time to time, in whole or in part, at the applicable redemption prices and at the times specified under “Description of Notes—Optional Redemption.” If we experience a change of control repurchase event with respect to a series of notes, we may be required to offer to purchase such series of notes from their holders. See “Description of Notes—Purchase of Notes upon a Change of Control Repurchase Event.” We expect to use the net proceeds from this offering, together with cash on hand, to repay the $1,500 million aggregate principal amount outstanding of our 5.600% senior notes due 2025 (the “2025 notes”) and pay accrued interest, related premiums, fees, and expenses in connection therewith. Pending the final application of the net proceeds of this offering, we may use such proceeds temporarily for general corporate purposes. See “Use of Proceeds.” The notes will be our senior